These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 2915235)

  • 21. Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Hawkins DS; Chi YY; Anderson JR; Tian J; Arndt CAS; Bomgaars L; Donaldson SS; Hayes-Jordan A; Mascarenhas L; McCarville MB; McCune JS; McCowage G; Million L; Morris CD; Parham DM; Rodeberg DA; Rudzinski ER; Shnorhavorian M; Spunt SL; Skapek SX; Teot LA; Wolden S; Yock TI; Meyer WH
    J Clin Oncol; 2018 Sep; 36(27):2770-2777. PubMed ID: 30091945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of rhabdomyosarcoma at the National Cancer Center Hospital].
    Beppu Y; Fukuma H; Chuma H; Ise T; Ohira M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1603-13. PubMed ID: 3592704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: a report of the Intergroup Rhabdomyosarcoma Study.
    Ortega JA; Wharam M; Gehan EA; Ragab AH; Crist W; Webber B; Wiener ES; Haeberlen V; Maurer HM
    J Clin Oncol; 1991 May; 9(5):796-801. PubMed ID: 2016622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee.
    Hays DM; Raney RB; Wharam MD; Wiener E; Lobe TE; Andrassy RJ; Lawrence W; Johnston J; Webber B; Maurer HM
    J Pediatr Hematol Oncol; 1995 Feb; 17(1):46-52. PubMed ID: 7743237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group.
    Pappo AS; Lyden E; Breitfeld P; Donaldson SS; Wiener E; Parham D; Crews KR; Houghton P; Meyer WH;
    J Clin Oncol; 2007 Feb; 25(4):362-9. PubMed ID: 17264331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.
    Arndt CA; Stoner JA; Hawkins DS; Rodeberg DA; Hayes-Jordan AA; Paidas CN; Parham DM; Teot LA; Wharam MD; Breneman JC; Donaldson SS; Anderson JR; Meyer WH
    J Clin Oncol; 2009 Nov; 27(31):5182-8. PubMed ID: 19770373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?
    Arndt CA; Donaldson SS; Anderson JR; Andrassy RJ; Laurie F; Link MP; Raney RB; Maurer HM; Crist WM
    Cancer; 2001 Jun; 91(12):2454-68. PubMed ID: 11413538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III.
    Andrassy RJ; Corpron CA; Hays D; Raney RB; Wiener ES; Lawrence W; Lobe TE; Bagwell C; Maurer HM
    J Pediatr Surg; 1996 Jan; 31(1):191-6. PubMed ID: 8632278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991.
    Raney RB; Asmar L; Newton WA; Bagwell C; Breneman JC; Crist W; Gehan EA; Webber B; Wharam M; Wiener ES; Anderson JR; Maurer HM
    J Clin Oncol; 1997 Feb; 15(2):574-82. PubMed ID: 9053479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soft tissue sarcomas arising in the retroperitoneal space in children. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee.
    Crist WM; Raney RB; Tefft M; Heyn R; Hays DM; Newton W; Beltangady M; Maurer HM
    Cancer; 1985 Oct; 56(8):2125-32. PubMed ID: 3896467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study.
    Hawkins DS; Anderson JR; Paidas CN; Wharam MD; Qualman SJ; Pappo AS; Scott Baker K; Crist WM
    J Clin Oncol; 2001 Jun; 19(12):3073-9. PubMed ID: 11408504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?
    Paulino AC; Pappo A
    Pediatr Blood Cancer; 2009 Dec; 53(7):1332-3. PubMed ID: 19711439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.
    Wharam MD; Meza J; Anderson J; Breneman JC; Donaldson SS; Fitzgerald TJ; Michalski J; Teot LA; Wiener ES; Meyer WH
    J Clin Oncol; 2004 May; 22(10):1902-8. PubMed ID: 15143083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paratesticular sarcoma in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Studies I and II, 1973-1983.
    Raney RB; Tefft M; Lawrence W; Ragab AH; Soule EH; Beltangady M; Gehan EA
    Cancer; 1987 Nov; 60(9):2337-43. PubMed ID: 3440240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary chemotherapy in the treatment of children with bladder--prostate tumors in the Intergroup Rhabdomyosarcoma Study (IRS-II).
    Hays DM; Raney RB; Lawrence W; Tefft M; Soule EH; Crist WM; Foulkes M; Maurer HM
    J Pediatr Surg; 1982 Dec; 17(6):812-20. PubMed ID: 6761418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis.
    Terwisscha van Scheltinga CE; Spronk P; van Rosmalen J; Wijnen MH; Heij HA; van Baren R; Merks JH; van Noesel MM; Wijnen RM
    J Pediatr Surg; 2014 Mar; 49(3):416-9. PubMed ID: 24650468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Childhood rhabdomyosarcoma].
    Morikawa Y
    Nihon Geka Gakkai Zasshi; 2005 Jul; 106(7):431-6. PubMed ID: 16045187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group.
    Pappo AS; Anderson JR; Crist WM; Wharam MD; Breitfeld PP; Hawkins D; Raney RB; Womer RB; Parham DM; Qualman SJ; Grier HE
    J Clin Oncol; 1999 Nov; 17(11):3487-93. PubMed ID: 10550146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.
    Pappo AS; Meza JL; Donaldson SS; Wharam MD; Wiener ES; Qualman SJ; Maurer HM; Crist WM
    J Clin Oncol; 2003 Feb; 21(4):638-45. PubMed ID: 12586800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (clinical groups III and IV). The Intergroup Rhabdomyosarcoma Study (IRS) Committee of the Cancer and Leukemia Group B Children's Cancer Study Group, Southwest Oncology Group.
    Raney RB; Gehan EA; Maurer HM; Newton WA; Ragab AH; Ruymann FB; Sutow WW; Tefft M
    Cancer Clin Trials; 1979; 2(1):19-28. PubMed ID: 391431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.